Exciting things are happening every day at VCU Massey Cancer Center. We’re saving lives and reducing suffering from cancer. We’re discovering new and better ways to prevent, diagnose and treat cancer. We’re offering opportunities for the community to join us in the progress against cancer.
Updates to outpatient care at Massey due to COVID-19
At VCU Massey Cancer Center we have implemented changes in our clinics to mitigate the coronavirus (COVID-19) situation and keep our patients and medical teams safe.
VCU Massey Cancer Center celebrated the final steel beam being raised to the top of its new world-class oncology pavilion in downtown Richmond with a virtual ceremony on Tuesday. The pavilion is part of a new 17-story, $384 million VCU Health Adult Outpatient Pavilion, the largest capital construction project in the health system’s history. The beam was decorated with handwritten messages of support and encouragement from members of the Massey community before being placed at the top of the building.
VCU Massey Cancer Center researcher Dipankar Bandyopadhyay, Ph.D., was recently elected as a member of the prestigious International Statistical Institute.
The International Statistical Institute (ISI) is a nonprofit organization founded in 1885 to promote the understanding, development and good practice of statistics worldwide. Elected membership is open to individuals who are established in their careers and have made noteworthy contributions to the statistical profession.
Researchers at VCU Massey Cancer Center are conducting an online study to understand how the COVID-19 crisis affects the perceptions and experiences of bone marrow transplant patients to identify specific areas of concern and challenges that could be addressed with available resources.
The laboratory of VCU Massey Cancer Center scientist Paula D. Bos, Ph.D., has joined forces with 18 other international laboratories to develop the first collaborative platform to streamline research into brain metastases. The effort, called the Brain Metastasis Cell Lines Panel (BrMPanel), has already compiled more than 60 different cell lines related to brain metastasis research in an effort to reduce research duplication and speed up therapeutic advancements.
VCU Massey Cancer Center researchers have been awarded a grant totaling more than $1.4 million over four years from the National Cancer Institute (NCI) to drive the development of a new treatment for MYCN-amplified neuroblastoma, an aggressive subset of pediatric nervous system cancer marked by overexpression of the MYCN gene. There are limited treatments currently available for MYCN-amplified neuroblastoma, and it is among the deadliest of the pediatric cancers.